HOUSTON--(BUSINESS WIRE)--Power3 Medical Products, Inc. (OTC: PWRM, www.Power3Medical.com), a leading proteomics company specializing in the development and commercialization of early detection diagnostic tests for breast cancer and neurodegenerative disease, has retained The Investor Relations Group, Inc. (IRG), based in New York City, to serve as its investor relations and corporate communications firm.
